AOSI HEALTHCARE TRIPLE ANTIBIOTIC
Active substance: BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE
OINTMENT · BACITRACIN ZINC 400 [USP'U]/g, NEOMYCIN SULFATE .0035 g/g, POLYMYXIN B SULFATE 5000 [USP'U]/g
United StatesActive
Marketing holder: Nantong Health & Beyond Hygienic Products Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- BACITRACIN ZINC · 400 [USP'U]/g
- NEOMYCIN SULFATE · .0035 g/g
- POLYMYXIN B SULFATE · 5000 [USP'U]/g
Registration
- Registration number
- 43473-053
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- TOPICAL
Sources
- product · openFDA NDC · 43473-053 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43473-053 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43473-053 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 43473-053 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 43473-053 · Verified 2026-10-09 · open in source